Viewing Study NCT06816966


Ignite Creation Date: 2025-12-24 @ 4:13 PM
Ignite Modification Date: 2025-12-24 @ 4:13 PM
Study NCT ID: NCT06816966
Status: ENROLLING_BY_INVITATION
Last Update Posted: 2025-02-10
First Post: 2025-01-16
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: Chemotherapy-immunotherapy-based Split-course Adaptive Hypofractionated Radiotherapy for Extensive-stage SCLC
Sponsor: Fujian Medical University Union Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module